Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
KEY PRODUCTS
KEY SERVICES
Reset all filters
01 1Cohance Lifesciences
Reset all filters
01 1TOLCAPONE USP
Reset all filters
01 1India
Reset all filters
01 1Active
Reset all filters
01 1Complete
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2015-07-10
Pay. Date : 2015-06-02
DMF Number : 28734
Submission : 2014-10-06
Status : Active
Type : II
20
Cohance Lifesciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
One of their notable products is TOLCAPONE USP, with a corresponding US DMF Number 28734.
Remarkably, this DMF maintains an Active status since its submission on October 06, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 10, 2015, and payment made on June 02, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II